Abstract
Background
Circular RNAs (circRNAs) have essential roles in the malignant progression of papillary thyroid carcinoma (PTC). Circ_0002111 was reported to facilitate cell proliferation and invasion abilities in PTC. This study was performed to explore the regulatory mechanism of circ_0002111 in PTC progression.
Methods
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used for the level detection of circ_0002111, microRNA-134-5p (miR-134-5p) and Follistatin Like 1 (FSTL1). Cell proliferation was assessed by 3-(4, 5-dimethylthiazol-2-y1)-2, 5-diphenyl tetrazolium bromide (MTT) assay, EdU assay and colony formation assay. Cell migration ability was determined by transwell assay. Glycolysis was analyzed by extracellular acidification rate (ECAR), oxygen consumption rate (OCR), glucose consumption and lactate production. The protein quantification was performed through western blot. Xenograft tumor assay was used for the functional analysis of circ_0002111 in vivo. The target interaction was confirmed by dual-luciferase reporter assay and RNA pull-down assay.
Results
The significant upregulation of circ_0002111 was detected in PTC samples and cells. PTC cell proliferation, migration and glycolytic metabolism were suppressed after circ_0002111 downregulation. PTC tumorigenesis in vivo was also inhibited by circ_0002111 knockdown. In addition, circ_0002111 could target miR-134-5p and si-circ_0002111#1-induced inhibition of PTC progression was relieved by miR-134-5p expression downregulation. Furthermore, FSTL1 was a target gene for miR-134-5p and miR-134-5p served as a tumor repressor in PTC by targeting FSTL1. Moreover, circ_0002111 could increase the FSTL1 level via sponging miR-134-5p.
Conclusion
All results indicated that circ_0002111 promoted the malignant behaviors of PTC cells partly by regulating the miR-134-5p/FSTL1 molecular network.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ren H, Ke N, Tan C et al (2020) Unusual metastasis of papillary thyroid cancer to the pancreas, liver, and diaphragm: a case report with review of literature [J]. BMC Surg 20(1):82
Abdullah MI, Junit SM, Ng KL et al (2019) Papillary thyroid cancer: genetic alterations and molecular biomarker investigations [J]. Int J Med Sci 16(3):450–460
Xu X, Jing J (2020) Advances on circRNAs contribute to carcinogenesis and progression in papillary thyroid carcinoma [J]. Front Endocrinol (Lausanne) 11:555243
Zembska A, Jawiarczyk-Przybylowska A, Wojtczak B et al (2019) MicroRNA expression in the progression and aggressiveness of papillary thyroid carcinoma [J]. Anticancer Res 39(1):33–40
Wang X, Li H, Lu Y et al (2020) Circular RNAs in human cancer [J]. Front Oncol 10:577118
Wang Y, Zong H, Zhou H (2021) Circular RNA circ_0062389 modulates papillary thyroid carcinoma progression via the miR-1179/high mobility group box 1 axis [J]. Bioengineered 12(1):1484–1494
Luo Q, Guo F, Fu Q et al (2021) hsa_circ_0001018 promotes papillary thyroid cancer by facilitating cell survival, invasion, G1/S cell cycle progression, and repressing cell apoptosis via crosstalk with miR-338-3p and SOX4 [J]. Mol Ther Nucleic Acids 24:591–609
Du G, Ma R, Li H et al (2021) Increased expression of hsa_circ_0002111 and its clinical significance in papillary thyroid cancer [J]. Front Oncol 11:644011
Gong J, Kong X, Qi J et al (2021) CircRNA_104565 promoted cell proliferation in papillary thyroid carcinoma by sponging miR-134 [J]. Int J Gen Med 14:179–185
Zhang L, Huang P, Li Q et al (2019) miR-134-5p promotes stage i lung adenocarcinoma metastasis and chemoresistance by targeting DAB2 [J]. Mol Ther Nucleic Acids 18:627–637
Zhong BZ, Wang Q, Liu F et al (2020) Effects of miR-384 and miR-134-5p acting on YY1 signaling transduction on biological function of gastric cancer cells [J]. Onco Targets Ther 13:9631–9641
Xue H, Wu Z, Rao D et al (2020) Long non-coding RNA LINC00858 aggravates the oncogenic phenotypes of ovarian cancer cells through miR-134-5p/RAD18 signaling [J]. Arch Gynecol Obstet 302(5):1243–1254
Hu Z, Zhao P, Zhang K et al (2020) Hsa_circ_0011290 regulates proliferation, apoptosis and glycolytic phenotype in papillary thyroid cancer via miR-1252/ FSTL1 signal pathway [J]. Arch Biochem Biophys 685:108353
Duan YR, Chen BP, Chen F et al (2021) LncRNA lnc-ISG20 promotes renal fibrosis in diabetic nephropathy by inducing AKT phosphorylation through miR-486–5p/NFAT5 [J]. J Cell Mol Med. https://doi.org/10.1111/jcmm.16280
Zhang C, Zhou X, Geng X et al (2021) Circular RNA hsa_circ_0006401 promotes proliferation and metastasis in colorectal carcinoma [J]. Cell Death Dis 12(5):443
Zhang M, Xu Y, Zhang Y et al (2021) Circular RNA circE2F2 promotes malignant progression of ovarian cancer cells by upregulating the expression of E2F2 protein via binding to HuR protein [J]. Cell Signal 84:110014
Wang Z, Liu C (2021) Upregulated hsa_circRNA_100269 inhibits the growth and metastasis of gastric cancer through inactivating PI3K/Akt axis [J]. PLoS ONE 16(4):e0250603
Zhang H, Zhang B, Zhang Y et al (2021) Downregulated hsa_circ_0036988 promotes proliferation and metastasis in oral squamous cell carcinoma [J]. Cancer Biomark 31(4):375–383
Schiliro C, Firestein BL (2021) Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation [J]. Cells 10(5):1056
Ganapathy-Kanniappan S (2018) Molecular intricacies of aerobic glycolysis in cancer: current insights into the classic metabolic phenotype [J]. Crit Rev Biochem Mol Biol 53(6):667–682
Wang Y, Miao C, Gao X (2021) TCEB3 is regulated by circ-0000212/miR-140-3p axis to promote the progression of cervical cancer [J]. Onco Targets Ther 14:2853–2865
Gao Q, Liu Q, Chen H (2021) Circular RNA hsa_circ_0000117 accelerates the proliferation and invasion of gastric cancer cells by regulating the microRNA-337-3p/signal transducer and activator of transcription 3 axis [J]. Bioengineered 12(1):1381–1390
Chen D, Ma W, Ke Z et al (2018) CircRNA hsa_circ_100395 regulates miR-1228/TCF21 pathway to inhibit lung cancer progression [J]. Cell Cycle 17(16):2080–2090
Acknowledgements
None
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Research involving human participants and/or animals
This article does not contain any studies directly involving human participants, as it is a review of data already collected in a hernia database.
lnformed consent
All participants provided informed consent prior to their participation.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, H., Jiang, J., He, X. et al. Circ_0002111/miR-134-5p/FSTL1 signal axis regulates tumor progression and glycolytic metabolism in papillary thyroid carcinoma cells. J Endocrinol Invest 46, 713–725 (2023). https://doi.org/10.1007/s40618-022-01921-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-022-01921-4